Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Vanda Pharmaceuticals (VNDA) Return on Invested Capital (2017 - 2025)

Vanda Pharmaceuticals' Return on Invested Capital history spans 9 years, with the latest figure at 0.16% for Q2 2025.

  • For Q2 2025, Return on Invested Capital fell 10.0% year-over-year to 0.16%; the TTM value through Jun 2025 reached 0.16%, down 10.0%, while the annual FY2025 figure was 0.55%, 49.0% down from the prior year.
  • Return on Invested Capital for Q2 2025 was 0.16% at Vanda Pharmaceuticals, down from 0.11% in the prior quarter.
  • Across five years, Return on Invested Capital topped out at 0.07% in Q3 2021 and bottomed at 0.16% in Q2 2025.
  • The 5-year median for Return on Invested Capital is 0.01% (2022), against an average of 0.0%.
  • The largest YoY upside for Return on Invested Capital was 3bps in 2021 against a maximum downside of -16bps in 2021.
  • A 5-year view of Return on Invested Capital shows it stood at 0.07% in 2021, then plummeted by -90bps to 0.01% in 2022, then plummeted by -252bps to 0.01% in 2023, then plummeted by -428bps to 0.05% in 2024, then tumbled by -191bps to 0.16% in 2025.
  • Per Business Quant, the three most recent readings for VNDA's Return on Invested Capital are 0.16% (Q2 2025), 0.11% (Q1 2025), and 0.05% (Q2 2024).